NBC Information: “Antibody checks will need to be in area for 2nd coronavirus wave, CDC director states,” April 13, 2020.
Yvonne Maldonado, MD, senior affiliate dean for school development and variety, professor of pediatrics — infectious ailments, and of wellness study and policy, Stanford University.
Aneesh Mehta, MD, affiliate professor, division of infectious ailments, Emory University School of Medication.
National Institutes of Health: “NIH commences study to quantify undetected conditions of coronavirus an infection,” April 10, 2020.
ClinicalTrials.gov: “SARS-COV2 Pandemic Serosurvey and Blood Sampling,” identifier NCT04334954.
Information release, Fda, April fifteen, 2020.
Fda: “Cellex qSARS-CoV-2 IgG/IgM Rapid Take a look at.”
Abbott: “Abbott Launches Third COVID-19 Take a look at, a Laboratory-Primarily based Antibody Blood Take a look at That Will Ship in the U.S. Starting Tomorrow,” April fifteen, 2020.
CIDRAP Information: “Antibody checks could keep clues to COVID-19 publicity, immunity — but it’s complex,” April fifteen, 2020.
“COVID-19 Dashboard by the Heart for Units Science and Engineering (CSSE) at Johns Hopkins University.”
Michael Mina, MD, PhD, assistant professor of epidemiology, Harvard T.H. Chan School of Community Health.
Matthew Sims, MD, PhD, director of infectious ailment study, Beaumont Health.
The Boston Globe: “Harvard president and spouse, equally recovered from coronavirus, strengthen scientists’ energy with blood donations,” April fourteen, 2020.
Marc Lipsitch, PhD, professor of epidemiology, Harvard T.H. Chan School of Community Health.